In a New Study, Treatment With JANUMET® (sitagliptin/metformin), Merck’s Diabetes Medicine, Resulted In Significantly …
In a New Study, Treatment With JANUMET® (sitagliptin/metformin), Merck’s Diabetes Medicine, Resulted In Significantly …
New data were presented at the American Diabetes Association (ADA) 70 th Annual Scientific Sessions from a study comparing JANUMET (sitagliptin/metformin) to pioglitazone.
Read more on Finanzen.net